Researchers at PNNL are pursuing new approaches to understand, predict and control the phenome—the collection of biological traits within an organism shaped by its genes and interactions with the environment.
Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.
Scientists at PNNL have published a new article that focuses on understanding the composition, dynamics, and deployment of beneficial soil microbiomes to get the most out of soil.
A team of researchers from PNNL provided technical knowledge and support to test a suite of techniques that detect genetically modified bacteria, viruses, and cells.
SAGE is a high-efficiency genome integration strategy for bacteria that makes the stable introduction of new traits simple for newly discovered microbes.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.
Chemist April Carman was recognized for her career accomplishments with the Professional Achievement Award from the University of Nevada, Reno, College of Science.
New study elucidates the complex relaxation kinetics of supercooled water using a pulsed laser heating technique at previously inaccessible temperatures.
PNNL's Rich Ozanich, project manager of opioids standards and equipment testing, served on an expert panel about opioid detection as part of a Department of Homeland Security S&T research and development showcase.
A new review paper led by senior research scientist Chun-Long Chen and featured on the cover of Accounts of Chemical Research summarizes advances by PNNL scientists in developing sequence-defined peptoids.
In a new video series, PNNL is highlighting six scientific and technical experts in the national security domain throughout the fall. Each was promoted to scientist and engineer Level 5, one of PNNL’s most senior research roles.
Researchers at PNNL have developed a bacteria testing system called OmniScreen that combines biological and synthetic chemistry with machine learning to hunt down pathogens before they strike.